Joseph P Hagan - Net Worth and Insider Trading
Joseph P Hagan Net Worth
The estimated net worth of Joseph P Hagan is at least $189,259 dollars as of 2024-06-05. Joseph P Hagan is the CEO of Regulus Therapeutics Inc and owns about 57,112 shares of Regulus Therapeutics Inc (RGLS) stock worth over $126,218. Joseph P Hagan is the Director of Aurinia Pharmaceuticals Inc and owns about 11,961 shares of Aurinia Pharmaceuticals Inc (AUPH) stock worth over $63,034. Joseph P Hagan is also the Sr. VP, Corporate Development of Orexigen Therapeutics Inc and owns about 1,303 shares of Orexigen Therapeutics Inc (OREXQ) stock worth over $7. Details can be seen in Joseph P Hagan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joseph P Hagan has not made any transactions after 2024-01-18 and currently still holds the listed stock(s).
Transaction Summary of Joseph P Hagan
Joseph P Hagan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joseph P Hagan owns 4 companies in total, including Regulus Therapeutics Inc (RGLS) , Zosano Pharma Corp (ZSANQ) , and Orexigen Therapeutics Inc (OREXQ) among others .
Click here to see the complete history of Joseph P Hagan’s form 4 insider trades.
Insider Ownership Summary of Joseph P Hagan
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RGLS | Regulus Therapeutics Inc | 2024-01-18 | Chief Operating Officer |
ZSANQ | Zosano Pharma Corp | 2020-06-25 | director |
OREXQ | Orexigen Therapeutics Inc | 2015-02-03 | Chief Business Officer |
2023-05-19 | director |
Joseph P Hagan Latest Holdings Summary
Joseph P Hagan currently owns a total of 3 stocks. Among these stocks, Joseph P Hagan owns 57,112 shares of Regulus Therapeutics Inc (RGLS) as of January 18, 2024, with a value of $126,218 and a weighting of 66.69%. Joseph P Hagan owns 11,961 shares of Aurinia Pharmaceuticals Inc (AUPH) as of May 19, 2023, with a value of $63,034 and a weighting of 33.31%. Joseph P Hagan also owns 1,303 shares of Orexigen Therapeutics Inc (OREXQ) as of September 15, 2014, with a value of $7 and a weighting of 0%.
Latest Holdings of Joseph P Hagan
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
RGLS | Regulus Therapeutics Inc | 2024-01-18 | 57,112 | 2.21 | 126,218 |
AUPH | Aurinia Pharmaceuticals Inc | 2023-05-19 | 11,961 | 5.27 | 63,034 |
OREXQ | Orexigen Therapeutics Inc | 2014-09-15 | 1,303 | 0.01 | 7 |
Holding Weightings of Joseph P Hagan
Joseph P Hagan Form 4 Trading Tracker
According to the SEC Form 4 filings, Joseph P Hagan has made a total of 12 transactions in Regulus Therapeutics Inc (RGLS) over the past 5 years, including 1 buys and 11 sells. The most-recent trade in Regulus Therapeutics Inc is the sale of 14,580 shares on January 18, 2024, which brought Joseph P Hagan around $17,350.
According to the SEC Form 4 filings, Joseph P Hagan has made a total of 1 transactions in Aurinia Pharmaceuticals Inc (AUPH) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Aurinia Pharmaceuticals Inc is the sale of 272 shares on May 19, 2023, which brought Joseph P Hagan around $2,878.
According to the SEC Form 4 filings, Joseph P Hagan has made a total of 0 transactions in Orexigen Therapeutics Inc (OREXQ) over the past 5 years. The most-recent trade in Orexigen Therapeutics Inc is the acquisition of 500 shares on September 15, 2014, which cost Joseph P Hagan around $23,450.
Insider Trading History of Joseph P Hagan
- 1
Joseph P Hagan Trading Performance
GuruFocus tracks the stock performance after each of Joseph P Hagan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph P Hagan is -7.64%. GuruFocus also compares Joseph P Hagan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph P Hagan within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joseph P Hagan's insider trading performs compared to the benchmark.
Performance of Joseph P Hagan
Joseph P Hagan Ownership Network
Ownership Network List of Joseph P Hagan
Ownership Network Relation of Joseph P Hagan
Joseph P Hagan Owned Company Details
What does Regulus Therapeutics Inc do?
Who are the key executives at Regulus Therapeutics Inc?
Joseph P Hagan is the Chief Operating Officer of Regulus Therapeutics Inc. Other key executives at Regulus Therapeutics Inc include Chief Financial Officer Crispina Calsada , Sr. VP & General Counsel Christopher Ray Aker , and President & Head of R & D Preston Klassen .
Regulus Therapeutics Inc (RGLS) Insider Trades Summary
Over the past 18 months, Joseph P Hagan made 1 insider transaction in Regulus Therapeutics Inc (RGLS) with a net sale of 14,580. Other recent insider transactions involving Regulus Therapeutics Inc (RGLS) include a net sale of 5,468 shares made by Christopher Ray Aker , a net sale of 5,468 shares made by Crispina Calsada ,
In summary, during the past 3 months, insiders sold 0 shares of Regulus Therapeutics Inc (RGLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,516 shares of Regulus Therapeutics Inc (RGLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 25,516 shares.
Regulus Therapeutics Inc (RGLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regulus Therapeutics Inc Insider Transactions
Joseph P Hagan Mailing Address
Above is the net worth, insider trading, and ownership report for Joseph P Hagan. You might contact Joseph P Hagan via mailing address: 3344 N. Torrey Pines Court, Suite 200, La Jolla Ca 92037.